Skip to content

Review of Multimodality Management of Anaplastic Thyroid Cancer

A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00280852
Enrollment
5
Registered
2006-01-24
Start date
2006-01-31
Completion date
2006-06-30
Last updated
2011-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaplastic Thyroid Cancer

Keywords

anaplastic thyroid cancer, chemotherapy, radiotherapy

Brief summary

To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy

Interventions

None listed

Sponsors

Alberta Health services
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* anaplastic thyroid cancer treated with multimodality treatment

Exclusion criteria

* differentiated thyroid cancer

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026